Outsourcing STREAM
-
The Heart Of The Matter: Early Vs. Late QT Prolongation Testing
2/8/2023
Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.
-
We Are Altasciences: Proactive Drug Development
1/30/2023
When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.
-
Altasciences Clinical Services At A Glance
1/30/2023
We can support your entire drug development program end to end, or you can partner with us for just one element. We offer you complete flexibility.
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
How To Boost Disclosure Efficiencies With Outsourcing
11/1/2018
In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.
-
Streamlining Patient Access To Cell And Gene Therapies
12/21/2023
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
An Innovative Approach To Functional Outsourcing
8/27/2025
The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.
-
Outsourcing Clinical Trial Disclosure Management
6/3/2020
Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.
-
The Path Forward, Altasciences' Approach To Project Management
3/19/2024
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
-
How To Take Advantage Of Early Access Programs For The EU
6/12/2024
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.